loadpatents
Patent applications and USPTO patent grants for PETO; Csaba J..The latest application filed is for "anti-cancer compounds".
Patent | Date |
---|---|
Anti-cancer Compounds App 20220267307 - PETO; Csaba J. ;   et al. | 2022-08-25 |
Anti-cancer compounds Grant 11,149,025 - Peto , et al. October 19, 2 | 2021-10-19 |
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer Grant 11,072,600 - Peto , et al. July 27, 2 | 2021-07-27 |
Anti-cancer Compounds App 20210009562 - PETO; Csaba J. ;   et al. | 2021-01-14 |
MEK Inhibitors and Methods of Their Use App 20200283383 - Aay; Naing ;   et al. | 2020-09-10 |
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer Grant 10,640,493 - Peto , et al. | 2020-05-05 |
Anti-cancer compounds Grant 10,562,886 - Peto , et al. Feb | 2020-02-18 |
Mek Inhibitors And Methods Of Their Use App 20200031770 - Aay; Naing ;   et al. | 2020-01-30 |
Phthalazine Derivatives as Inhibitors of PARP1, PARP2, and/or Tubulin Useful for the Treatment of Cancer App 20190352283 - PETO; Csaba J. ;   et al. | 2019-11-21 |
Phthalazine Derivatives as Inhibitors of PARP1, PARP2, and/or Tubulin Useful for the Treatment of Cancer App 20190337928 - PETO; Csaba J. ;   et al. | 2019-11-07 |
MEK Inhibitors and Methods of Their Use App 20190144382 - Aay; Naing ;   et al. | 2019-05-16 |
Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof Grant 10,266,518 - Rice , et al. | 2019-04-23 |
Anti-cancer Compounds App 20180354932 - PETO; Csaba J. ;   et al. | 2018-12-13 |
Receptor-Type Kinase Modulators and Methods of Use App 20180118724 - Rice; Kenneth D. ;   et al. | 2018-05-03 |
Substituted quinazolines as receptor-type kinase inhibitors Grant 9,796,704 - Rice , et al. October 24, 2 | 2017-10-24 |
MEK Inhibitors And Methods Of Their Use App 20170166523 - Aay; Naing ;   et al. | 2017-06-15 |
Processes for the preparation of substituted quinazolines Grant 9,359,332 - Rice , et al. June 7, 2 | 2016-06-07 |
Receptor-Type Kinase Modulators and Methods of Use App 20160129032 - Rice; Kenneth D. ;   et al. | 2016-05-12 |
MEK Inhibitors And Methods Of Their Use App 20150141399 - Aay; Naing ;   et al. | 2015-05-21 |
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20140275527 - Aay; Naing ;   et al. | 2014-09-18 |
Receptor-Type Kinase Modulators and Methods of Use App 20140155418 - Rice; Kenneth D. ;   et al. | 2014-06-05 |
Raf modulators and methods of use Grant 8,697,737 - Anand , et al. April 15, 2 | 2014-04-15 |
Receptor-type kinase modulators and methods of use Grant 8,658,654 - Rice , et al. February 25, 2 | 2014-02-25 |
Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture Grant 8,648,066 - Anand , et al. February 11, 2 | 2014-02-11 |
Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture Grant 8,637,499 - Aay , et al. January 28, 2 | 2014-01-28 |
Pyrazolo pyrimidines as casein kinase II (CK2) modulators Grant 8,372,851 - Rice , et al. February 12, 2 | 2013-02-12 |
Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 8,362,002 - Aay , et al. January 29, 2 | 2013-01-29 |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture App 20120258953 - Aay; Naing ;   et al. | 2012-10-11 |
Pyrimidinones as Casein Kinase II (CK2) modulators Grant 8,101,625 - Rice , et al. January 24, 2 | 2012-01-24 |
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20110263558 - Aay; Naing ;   et al. | 2011-10-27 |
Tropane compounds Grant 8,012,956 - Rice , et al. September 6, 2 | 2011-09-06 |
Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 7,915,250 - Aay , et al. March 29, 2 | 2011-03-29 |
Raf Modulators And Methods Of Use App 20110071145 - Anand; Neel Kumar ;   et al. | 2011-03-24 |
Anaplastic lymphoma kinase modulators and methods of use Grant 7,872,014 - Anand , et al. January 18, 2 | 2011-01-18 |
Raf modulators and methods of use Grant 7,846,959 - Anand , et al. December 7, 2 | 2010-12-07 |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture App 20100298290 - Anand; Neel Kumar ;   et al. | 2010-11-25 |
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20100249096 - Aay; Naing ;   et al. | 2010-09-30 |
Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 7,803,839 - Aay , et al. September 28, 2 | 2010-09-28 |
Pyrazolo-Pyrimidines as Casein Kinase II (CK2) Modulators App 20100130488 - Rice; Kenneth D. ;   et al. | 2010-05-27 |
Protein kinase modulators and methods of use Grant 7,704,995 - Buhr , et al. April 27, 2 | 2010-04-27 |
Receptor-type kinase modulators and methods of use App 20090318373 - Rice; Kenneth D. ;   et al. | 2009-12-24 |
Pyrimidinones as Casein Kinase II (CK2) Modulators App 20090215803 - Rice; Kenneth D. ;   et al. | 2009-08-27 |
Receptor-type kinase modulators and methods of use Grant 7,576,074 - Rice , et al. August 18, 2 | 2009-08-18 |
Tropane compounds App 20090163471 - Rice; Kenneth D. ;   et al. | 2009-06-25 |
Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20090156576 - Aay; Naing ;   et al. | 2009-06-18 |
Raf Modulators and Methods of Use App 20080009488 - Anand; Neel Kumar ;   et al. | 2008-01-10 |
Anaplastic lymphoma kinase modulators and methods of use App 20070032515 - Anand; Neel Kumar ;   et al. | 2007-02-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.